OpenAlex
PricingAboutJobs
Log inGet started
Work

Genome-wide pharmacogenetic investigation of a hepatic adverse event without clinical signs of immunopathology suggests an underlying immune pathogenesis

HTML

Year: 2007
Type: article
Study design: Observational Study
Source: The Pharmacogenomics Journal
DOI: 10.1038/sj.tpj.6500458
Authors: A Kindmark, A Jawaid, C G Harbron, B J Barratt, O F Bengtsson, T B Andersson, S Carlsson, K E Cederbrant, N J Gibson, M Armstrong, M E Lagerström-Fermér, A Dellsén, E M Brown, M Thornton, C Dukes, S C Jenkins, M A Firth, G O Harrod, T H Pinel, S M E Billing-Clason, L R Cardon, R E March
Institutions: AstraZeneca (Sweden), AstraZeneca (United Kingdom), Centre for Human Genetics, University of Oxford
Language: English

Topic: Pharmacogenetics and Drug Metabolism
Subfield: Pharmacology
Field: Pharmacology, Toxicology and Pharmaceutics
Domain: Life Sciences
Keywords: ximelagatran, direct thrombin inhibitors, drug-induced liver injury, alanine aminotransferase elevation, MHC class II alleles, HLA-DRB1*07, immune-mediated adverse drug reactions, contact sensitizers, drug hypersensitivity
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2055128986
FWCI: 17.18
Cites: 31
Cited by: 384
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms